Michigan Medicaid Now Reimbursing rWGS® for Critically-Ill Infants*
On September 1, 2021, Michigan became the first state to make rapid Whole Genome Sequencing™ a covered benefit for eligible infants enrolled in Medicaid. This makes available the most advanced diagnostic test of rare genetic disease for babies in intensive care.
Sign up today to receive a resource pack for Michigan hospitals interested in providing this emerging standard of care diagnostic test.
What You'll Get:
The latest on reimbursement policies around the United States
Quick guide to implementing rapid Whole Genome Sequencing™
Pre-filled Michigan Medicaid Reimbursement Form
*Now reimbursable, contingent upon approval of a State Plan Amendment (SPA) by the Centers for Medicare & Medicaid Services (CMS).
WHAT PEOPLE ARE SAYING ABOUT RAPID WHOLE GENOME SEQUENCING
In the field of genetics right now, in my opinion, this is very much standard of care.
— Caleb Bupp, Medical Genetics & Genomics Division Chief, Spectrum Health
About Us
Rady Children’s Institute for Genomic Medicine is a non-profit research organization embedded within Rady Children’s Hospital-San Diego.
Along with optimizing our genome sequencing platform and Rapid Precision Medicine delivery system, we are scaling and sharing our tools and expertise in rare disease with a growing network of children’s hospitals globally to make cutting edge healthcare widely available.
